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A B S T R A C T
Cellular senescence is characterized by irreversible growth arrest incurred through either replicative exhaustion
or by pro-oncogenic cellular stressors (radioactivity, oxidative stress, oncogenic activation). The enrichment of
senescent cells in tissues with age has been associated with tissue dyshomeostasis and age-related pathologies
including cancers, neurodegenerative disorders (e.g. Alzheimer's, Parkinson's, etc.) and metabolic disorders (e.g.
diabetes). We identiﬁed copper accumulation as being a universal feature of senescent cells [mouse embryonic
ﬁbroblasts (MEF), human prostate epithelial cells and human diploid ﬁbroblasts] in vitro. Elevated copper in
senescent MEFs was accompanied by elevated levels of high-aﬃnity copper uptake protein 1 (Ctr1), diminished
levels of copper-transporting ATPase 1 (Atp7a) (copper export) and enhanced antioxidant defence reﬂected by
elevated levels of glutathione (GSH), superoxide dismutase 1 (SOD1) and glutaredoxin 1 (Grx1). The levels of
intracellular copper were further increased in senescent MEFs cultured in copper supplemented medium and in
senescent Mottled Brindled (Mobr) MEFs lacking functional Atp7a. Finally, we demonstrated that the restoration/
preservation of autophagic-lysosomal degradation in senescent MEFs following rapamycin treatment correlated
with attenuation of copper accumulation in these cells despite a further decrease in Atp7a levels. This study for
the ﬁrst time establishes a link between Atp7a and the autophagic-lysosomal pathway, and a requirement for
both to eﬀect eﬃcient copper export. Such a connection between cellular autophagy and copper homeostasis is
signiﬁcant, as both have emerged as important facets of age-associated degenerative disease.
1. Introduction
Cellular senescence represents a critical barrier against cellular
transformation and prevents the uncontrolled proliferation of cells that
are irrevocably damaged [13,63]. Senescent cells actively secrete a
variety of proteins, including pro-inﬂammatory mediators (cytokines
and chemokines) to elicit immunological self-clearance [13,73]. Other
secreted factors facilitate communication with the local microenviron-
ment and can establish senescence in neighbouring cells in a paracrine
manner [50,53]. The beneﬁcial roles of senescent cells, for instance in
wound healing, tissue remodelling and against cancer development, are
considered conditional on their eﬃcient and timely tissue clearance
[13,73]. However, senescent cells accumulate in tissues and organs
with age and contribute to age-related pathologies and dysfunction, in
part, through promoting chronic inﬂammation [13,73]. Why senescent
cells accumulate with age is unclear, but it is likely to be associated
with age-associated immunodeﬁciency and therefore reduced clearance
[17,54,67,74]. Recently developed strategies to clear senescent cells in
vivo have provided remarkable improvement to the healthspan of mice
by attenuating age-related pathologies and tissue dysfunctions
[2–4,16,77].
We previously provided an aetiological link between senescent cell
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enrichment and iron dyshomeostasis, both of which occur in tissues
with ageing and at sites of age-related pathologies [44]. We demon-
strated that senescent cells accumulate substantial amounts of in-
tracellular iron (up to 30-fold) as a consequence of impaired ferritino-
phagy (ferritin degradation) [44]. Elevated ferritin proved to be a
robust biomarker for cellular senescence, for associated iron accumu-
lation and for resistance to iron-induced toxicity, including ferroptosis.
[44]. In this study, we further investigated whether other biologically
relevant metals are altered in cellular senescence and identiﬁed a
consistent increase in intracellular copper. Several groups have pre-
viously reported that elevated copper (250–500 µM) induces premature
senescence in certain cell types [e.g. human diploid ﬁbroblasts and fetal
lung ﬁbroblasts] [8,41,47,48,60], which can be attenuated by the
copper chelator resveratrol [6,48,69]. Furthermore, replicative senes-
cent human diploid ﬁbroblasts (HDFs) have been shown to accumulate
copper (2-fold) [8] and harbour increased mRNA transcript levels for
copper-regulated genes, heat shock protein 70, metallothionein 2A and
prion protein [60]. We hypothesized that copper accumulation is a
feature of cellular senescence and investigated the cellular modiﬁca-
tions that potentially contributed to elevated copper levels, such as
enhanced antioxidant mechanisms and alterations to key copper
homeostasis proteins. Further, we describe the key role of lysosomal
dysfunction in senescence-associated copper accumulation.
2. Experimental
2.1. Chemicals and reagents
Rapamycin was purchased from Thermo Fischer Scientiﬁc
(Cat#FSBBP2963-1). Baﬁlomycin A1 (Baf A1) (Cat# B1793) was pur-
chased from Sigma Aldrich. All other reagents were purchased from
Sigma Aldrich unless otherwise stated.
2.2. Isolation and culturing of primary mouse and human cells
Primary mouse embryonic ﬁbroblasts (MEFs) were collected from
sacriﬁced pregnant mice [C57BL/6 wild-type, Li-Fraumeni syndrome
C57BL/6, agouti, mottled brindle (Mobr) mice] at 13 day post-coitum
and cultured as described previously [44]. Li-Fraumeni syndrome leads
to a predisposition to tumor development in individuals that carry in-
herited mutations in tumor suppressor gene TP53 [39]. The Li-Frau-
meni syndrome C57BL/6 mice, that harbour a TP53 germline mutation
(G515A nucleotide mutation), were a kind gift from Prof. Guillermina
Lozano (University of Texas) [39]. This study was approved by the
Deakin University Animal Ethics Committee (AEC) (Id#G01–2014).
Primary human diploid ﬁbroblasts (HDFs) (S103) obtained from the
Murdoch Children's Research Institute, Melbourne, and human primary
prostate epithelial cells (PrECs), purchased from Lonza (Cat#CC-2555)
were cultured as described previously [44].
2.3. Screening of MEFs carrying copper-transporting ATPase 1 (Atp7a)-
Mobr mutation
MEFs were screened for presence of Atp7a-Mobr mutation by poly-
merase chain reaction (PCR) as described previously [42]. Brieﬂy, sense
oligonucleotides MMNK22 (5’-GGCAAAACCTCCGAGGCAAAG) speciﬁc
for Atp7a-Mobr mutation or MMNK23 (5’- CAAAACCTCCGAGGCTCT
TGC) speciﬁc for wild-type Atp7a and antisense oligonucleotide
MMNK24L (5’-AGGAGGAGATTTTCAGAGTTCAG-3’) were used to am-
plify products of 83 bp and 87 bp, respectively, in separate reaction
tubes. PCR conditions were as follows: 96 °C for 4min, 63 °C for 1min,
72 °C for 1min for two cycles followed by 96 °C for 1min, 63 °C for
1min, 72 °C for 30 s for 35 cycles. The PCR products were resolved on a
4% agarose (agarose 3:1 High Resolution Blend, AMRESCO) gel and
detected by staining with ethidium bromide.
2.4. Senescence induction by ionizing radiation
Senescence was induced in primary mouse and human cell lines
(MEFs, HDFs and PRECs) as previously described [44]. Brieﬂy, cells
were cultured to ~ 90% conﬂuence in 25 or 75 cm2 ﬂasks (Cellstar®,
Cat#690175 or 658175, respectively) and subjected to 10 Gray (Gy)
gamma irradiation using a calibrated Cesium-137 source (Gamma Cell
40, Atomic energy of Canada Limited). Cellular senescence was as-
sessed at appropriate time points (in days) post-irradiation by senes-
cence-associated β-galactosidase (SA-βgal) activity staining, as detailed
in the Results.
2.5. Retrovirus production and transduction of primary MEFs
HEK293T cells were cultured in DMEM medium supplemented with
10% FBS, penicillin (20 U/mL) and streptomycin (20 μg/mL), and were
used as a packaging cell line for retrovirus production used for trans-
duction of MEFs as described previously [44]. To produce retrovirus
containing the SV40 Large T antigen (SV40 LgT), equimolar amounts of
pBabe-neo large TcDNA plasmid (Addgene, Cat#1780) along with the
packaging plasmid pCl-Eco (Addgene, Cat#12371) were used. Retro-
virus containing the oncogene H-RasV12 was produced with pWZL-
Hygro H-Ras V12 plasmid (Addgene, Cat#18749), while control ret-
rovirus was produced with empty pWZL-Hygro plasmid (Addgene,
Cat#18750).
2.6. Senescence-associated β-galactosidase assay in cells
SA-βgal staining of cultured cells was performed as previously de-
scribed [44]. The percentage of cells stained for SA-βgal activity was
determined using an inverted microscope (Olympus IX51), by counting
cells in four random ﬁelds of view at a magniﬁcation of 200/400X.
Images were taken with Canon 1100D digital camera.
2.7. Western blotting analyses
Cell lysates were prepared and fractionated as described previously
[44]. Gel fractionated protein samples were transferred to ni-
trocellulose membrane using Bolt® transfer system and buﬀer con-
taining Tris-HCl (25mM), glycine (192mM) and 15% methanol (5% for
Atp7a). Membranes were blocked for 1 h at room temperature using 5%
(w/v) skimmed milk in wash (TBS-T) buﬀer containing Tris-HCl
[10mM (pH 8.0), NaCl (150mM) and 0.1% Tween-20]. The following
antibody dilutions were used: anti-CCS (Cat#FL274, 1:1000) was pur-
chased from Santa Cruz Biotechnology, USA. Anti-β-actin (Cat#A5441,
1:10000), anti-LC3B (Cat#L7543, 1:1000) and HRP conjugated anti-
goat IgG (Cat#A5420, 1:5000) were purchased from Sigma Aldrich.
Anti-high-aﬃnity copper uptake protein 1 (Ctr1) (Cat#EPR7936,
1:1000) and anti-Grx1 (Cat#AB16877, 1:1000) were purchased from
Abcam. Anti-SOD1 (ADI-SOD-100, 1:2000) was purchased from Enzo
Lifesciences, USA. Anti-Atp7a (R17, 1:500), goat polyclonal, was raised
in-house and aﬃnity puriﬁed. HRP conjugated goat-anti-mouse
(Cat#P0447) and goat-anti-rabbit (Cat#P0448) antibodies were pur-
chased from Dako. The membranes were subsequently developed using
ECL reagent (Millipore, Cat#WBKLS0500) and bands visualized on Gel
Dock™ XR+ system (Bio-Rad). At least three independent experiments
were used for all comparisons.
2.8. Determination of total intracellular copper
Total copper concentration was measured by inductively coupled
plasma mass spectrometry (ICP-MS, Agilent 7700, Varian). Tissue cul-
ture cells were prepared for ICP-MS analyses as previously described
[44]. Unit conversions from raw ppb values were performed as follows:
(ng/million cells) = (raw ppb values × dilution factor/cell number).
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2.9. Total glutathione determination
Reduced (GSH) and oxidized (GSSG) glutathione were measured by
HPLC with permanganate chemiluminescence detection using a GloCel
detector with serpentine ﬂow-cell [49,66,71]. Cell pellets were homo-
genized (vortexed) in 300 µL of 0.1% formic acid and then centrifuged
at 5000× g at 4 °C for 15min. For GSH determination, the supernatant
was diluted 10-fold in aqueous formic acid (5%) immediately prior to
analysis. For GSSG determination a second aliquot of the supernatant
(100 µL) was combined with 20 µL of 675mM Tris-HCl buﬀer (pH 8.0)
and 20 µL of 6.3mM N-ethylmaleimide (NEM) to block endogenous
GSH, and mixed for 30 s. Then 20 µL of 8mM 2-mercaptoethanol was
added and mixed for a further 30 s. Subsequent to adding 20 µL of
780 nM TCEP, the solution was gently heated at 50 °C for 60min to
allow complete disulﬁde bond reduction. Finally, 20 µL of aqueous
formic acid (5%) was introduced to re-acidify the sample prior to
analysis.
2.10. Cell size determination
The diameter of suspended cells was determined by using a Coulter
Z2 Cell Count and Size Analyser, as described previously [44].
2.11. Statistical and image analyses
Statistical analyses were performed using student-t-tests, using
GraphPad PRISM (version 6.0b) software. All data are represented as
mean± SD; probabilities of p < 0.05 were considered signiﬁcant.
3. Results and discussion
3.1. Senescent cells accumulate intracellular copper
We initially investigated whether cellular senescence is associated
with altered copper homeostasis using primary mouse embryonic ﬁ-
broblasts (MEFs) [23,44]. Senescence was induced by either sub-lethal
gamma irradiation (10 Gy) or replicative exhaustion as described pre-
viously [44] and was conﬁrmed through staining for senescence-asso-
ciated beta-galactosidase (SA-βgal) activity (Fig. 1A). Note that primary
MEFs underwent replicative exhaustion at passage 7 under our cul-
turing conditions. More than 80% of MEFs stained positive for SA-βgal
activity when cultured for a minimum of 10 days following either mode
of senescence induction (Fig. 1A). Senescent cells remain metabolically
active in culture for many months [44,73] and we therefore maintained
senescent MEFs for 21 days to allow for a net change in intracellular
copper to occur (Fig. 1B). Both irradiated (MEF IR) and replicative
senescent (MEF REP) MEFs accumulated a signiﬁcant amount of copper
(~ 3–4-fold, respectively) when compared to primary proliferative
MEFs (MEF PRI) (Fig. 1B). Variation in cell diameter (suspended), or
total cellular protein content, between senescent (irradiated and re-
plicative) and primary MEFs could not account for the degree of in-
creased intracellular copper (Fig. 1C). Senescence induction and
maintenance in murine cells is reliant on wild-type p53 function, the
loss of which can result in senescence bypass/immortalization
[24,31,73]. Both irradiation and replicative exhaustion lead to senes-
cence induction through p53-mediated DNA damage response (DDR)
pathways [73]. Accordingly, primary MEFs isolated from mice har-
bouring mutant p53 (G515A nucleotide mutation), which impairs se-
nescence induction by irradiation [39,44], accumulated negligible
amounts of intracellular copper post-irradiation (10 Gy) (Fig. 1D).
Therefore, copper accumulation concomitant with senescence required
wild-type p53 function and was not indirectly caused by irradiation.
Likewise, wild-type MEFs that we aided to spontaneously bypass se-
nescence using the 3T3 culturing method [ISO(3T3)] [72], had in-
tracellular copper levels (Fig. 1E) comparable to primary MEFs (iso-
genic) (P4) (Fig. 1F). Note that senescence-bypass in MEFs commonly
occurs through mutation of p53, leading to immortalization [30,59].
Therefore, copper accumulation in MEFs was not sustained following
senescence bypass. Furthermore, MEFs immortalized with SV40 large T
(LT) antigen (MEF LT) (Fig. 1G) and cultured also had intracellular
copper levels comparable to primary MEFs (MEF PRI) (Fig. 1F). Thus,
accumulation of copper was a feature of senescent MEFs (IR or REP)
and was absent in primary and senescence bypassed/immortalized
MEFs.
Oncogenes such as HRasV12 can transform immortalized cells
making them tumourigenic, but can also induce senescence in primary
(non-immortalized) cells [63]. Oncogene-induced senescence (OIS) is
distinct from irradiation and replicative-induced senescence and shares
similar features with programmed developmental senescence
[18,33,67]. We therefore transduced primary MEFs with HRasV12 and
veriﬁed senescence induction through SA-βgal activity staining at 8
days post-transduction (MEF OIS) (Fig. 1H(i)). Oncogene-induced
(HRasV12) senescent MEFs (MEF OIS) accumulated intracellular copper
when compared to MEFs transduced with control retrovirus (MEF VC)
(Fig. 1H(ii)), despite the limited percentage of senescent cells (> 50%).
In contrast, immortalized MEFs transduced with retrovirus containing
HRasV12 (MEF LT Ras) had slightly reduced intracellular copper levels
(Fig. 1H(ii)), demonstrating that HRasV12 expression alone does not
cause copper accumulation. Taken together, these results demonstrate
that copper accumulated speciﬁcally in MEFs following senescence in-
duction through irradiation (10 Gy), replicative exhaustion, or the
HRasV12 oncogene.
We further demonstrated that human primary diploid ﬁbroblast
(HDFs) and human prostate epithelial cells (PrECs), analogous to MEFs,
also accumulated intracellular copper following senescence induction
through irradiation (IR) (Fig. 1I). Therefore, our results demonstrate
that intracellular copper accumulates in senescent cells irrespective of
stimuli or cell origin and is therefore likely to represent a universal
feature.
3.2. Copper accumulation in senescent cells is associated with altered copper
homeostatic mechanisms
We investigated the levels of key cellular copper homeostasis pro-
teins in senescent MEFs (21 days post-irradiation) (Fig. 2A). Western
blot analyses revealed that senescent MEFs (MEFs IR) had signiﬁcantly
elevated levels of the high-aﬃnity copper-uptake protein 1 (Ctr1), the
principle protein responsible for the cellular uptake of copper (Fig. 2A).
Ctr1 is the major copper import protein and resides as a trimeric
complex that creates a pore through the plasma membrane (Fig. S1A)
[40]. The transmembrane P1B-type ATPase Atp7a in most cells (e.g.
ﬁbroblasts and epithelial cells) facilitates removal of excess copper
across the plasma membrane [52,55]. The expression of Atp7a was
signiﬁcantly reduced in senescent MEFs (21 days post-irradiation)
(Fig. 2A), which, in combination with elevated Ctr1, potentially con-
tributed to their net increase in intracellular copper. Analogous changes
to Ctr1 and Atp7a were also observed in replicative senescent MEFs
(Fig. S1B). There was no change in Atp7a transcript levels post senes-
cence induction (not shown), making it likely that the reduced Atp7a
protein levels were a consequence of post-translational mechanisms,
such as selective degradation via the ubiquitin-proteasome pathway
[21,22,46]. Conceivably, the increase in intracellular copper in senes-
cent cells would necessitate numerous adaptive changes by the cell to
prevent toxicity from the production of reactive oxygen species (ROS).
Therefore, we next investigated the levels of known antioxidants that
aﬀord cellular protection against copper-induced oxidative stress. Su-
peroxide dismutase 1 (SOD1) scavenges superoxide anions, utilizes
copper as a cofactor [76] and is a reliable marker of cellular stress [1].
SOD1 was markedly elevated in senescent MEFs (21 days post-irra-
diation) (Fig. 2B). The level of the copper chaperone for SOD1 (CCS)
[62,76] remained unchanged suggesting that accumulated copper may
be present in a bound state possibly sequestered by proteins (e.g.
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glutaredoxins, metallothioneins) or cytosolic antioxidants [e.g. glu-
tathione (GSH)] (Fig. 2B) [5]. Glutaredoxin 1 (Grx1) is a GSH-depen-
dent thiol-oxidoreductase that protects cellular proteins from oxidative
damage by catalysing the reversible oxidation of protein thiols by GSSG
to form mixed disulﬁdes (P-SSG) (glutathionylation) or intramolecular
disulﬁdes (P-SS) [9,11,32]. Grx1 was previously shown to protect cells
from copper-induced toxicity [15,65]. When the oxidative challenge is
removed Grx1 may then catalyse the reverse reactions
(deglutathionylation, reduction of intramolecular disulﬁde bonds) [11].
Analogous to SOD1, Grx1 expression is markedly elevated in senescent
MEFs (21 days post-irradiation) (Fig. 2B). Grx1 also was demonstrated
to bind copper with high aﬃnity [11] and potentially could bind the
accumulated copper. GSH as the major cellular antioxidant, is rich in
the cytosol (1–10mM) [25] and may be reversibly oxidized to its dis-
ulﬁde form GSSG. The GSSG/GSH couple constitutes a redox buﬀer that
controls the redox status of cellular protein thiols among other
(caption on next page)
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antioxidative functions [61]. GSH has also been shown to play an im-
portant intermediary role in handling intracellular copper immediately
following cellular uptake by Ctr1 [19,20,43] and may also mediate the
loading of copper onto SOD1 through a CCS-independent mechanism
[34,76]. GSH may bind the majority of cytosolic copper and can allow
cells to accommodate elevated levels of copper while mitigating asso-
ciated oxidative damage [27,5]. Furthermore, the level and ratio of
GSH to GSSG can often serve as an indicator of the cellular redox status
[61]. Since oxidative stress is a well-characterized feature of senescent
cells [28,36], coupled with a marked increase in copper levels, we
postulated that changes to the levels of GSH and the GSH/GSSG ratio
would likely occur in senescent cells. In senescent MEFs (21 days post-
irradiation) there was a substantial increase in both reduced GSH (~ 5-
fold) and oxidized GSSG (~ 7-fold), combined with a lower ratio of
GSH:GSSG (Fig. 2C). Replicative senescent MEFs showed similar
changes in GSH and GSSG levels (Fig. S1C). Taken together, these re-
sults demonstrate that copper accumulation in senescent cells is asso-
ciated with changes in the expression proﬁle of relevant copper
homeostatic proteins. Furthermore, a concomitant increase in major
cellular antioxidants, SOD1, Grx1 and GSH, may protect senescent cells
against the adverse eﬀects of oxidative stress. In the case of GSH and
Grx1, this protection may occur through mechanisms that include the
binding or sequestering of accumulated copper.
3.3. Dose-dependent copper accumulation in senescent MEFs is exacerbated
in the absence of Atp7a
Senescent cells remain metabolically active and undergo morpho-
logical and biochemical changes correlating with diﬀerent phases in
their progression [73]. We therefore determined whether the degree of
copper accumulation in senescent MEFs reﬂected the duration of time
in culture and/or the availability of copper in the extracellular milieu.
Copper accumulation was monitored in irradiated MEFs following dif-
ferent time periods in culture (1, 7, 14 and 21 days) (Fig. 3A). Note that
the medium was replenished weekly for each time point. Intracellular
copper accumulated in irradiated cultures and correlated with the in-
creasing percentage of senescent cells at each time point (Fig. 3A).
However, the level of accumulated copper somewhat plateaued but was
maintained after day 14, indicating that an upper threshold may have
been reached (Fig. 3A). Similarly, MEFs undergoing replicative ex-
haustion progressively accumulated intracellular copper in accordance
with the percentage of senescent cells at each passage, reaching an
upper limit when cells at passage 7 were cultured for 10 days (Fig. 3B).
Further culturing of replicative senescent MEFs (21 days) did not aug-
ment copper accumulation (Fig. 3B). To establish whether these ap-
parent upper thresholds were dependent on milieu copper, we treated
both irradiated (14 days post-irradiation) and replicative senescent
MEFs (passage 7 cultured for 10 days) with either basal medium or
media supplemented with 20 µM CuCl2 for 24 h (Fig. 3C). Note that
primary proliferative MEFs (passage 4) were treated equivalently as a
control (Fig. 3C). In medium supplemented with 20 µM CuCl2 there was
an increase in the capacity of senescent MEFs (IR and REP) to accu-
mulate intracellular copper (Fig. 3C). The reason for the higher copper
accumulation in irradiated senescent MEFs compared to replicative
senescent MEFs is currently unclear.
We next investigated the importance of Atp7a activity on the extent
of copper accumulation in senescent cells. We utilized the brindled
mouse mutant (Mobr) that most closely models Menkes disease (MD), an
X-linked recessive copper-deﬁciency disorder caused by mutation(s) in
the ATP7A gene (human orthologue of mouse Atp7a) [29]. Mobr mice
harbour a 6 base-pair deletion (GCTCTT from nucleotides 2473–2478)
in Atp7a, resulting in the in-frame deletion of two amino acids; an
alanine residue (Ala799) and a highly conserved leucine residue
(Leu800). While cells and tissue fromMobrmice display normal levels of
Atp7a transcript and protein, the protein fails to eﬃciently mediate
copper eﬄux [29,37]. Analogous to human MD ﬁbroblasts, several cell
types isolated from Mobr mice, such as lung ﬁbroblasts, kidney epithe-
lial cells and fetal cells were reported to harbour elevated copper (~ 4-
fold, ~ 7-fold and ~ 21-fold, respectively) when compared to coun-
terpart normal cells in culture [12]. We generated MEFs from Mobr and
agouti (same background as Mobr: wtAtp7a) mouse embryos and sub-
sequently irradiated them to induce cellular senescence. We established
that 10 days following irradiation, more than 80% of MEFs from both
Mobr (MEF-Mobr) and agouti [MEF (A)] mice stained positive for SA-
βgal activity (Fig. 3D(i)), analogous to MEFs from the C57BL/6 back-
ground (Fig. 1A). Both irradiated Mobr (MEF-Mobr) and agouti [MEF
Fig. 1. Senescent cells accumulate copper. (A) Primary (non-immortalized) mouse embryonic ﬁbroblasts (MEFs) were induced to senescence by either sub-lethal gamma irradiation
(10 Gy) or replicative exhaustion. Senescent cell population in culture was determined through staining for senescence-associated beta-galactosidase (SA-βgal) activity (blue staining).
Note that primary MEFs underwent replicative exhaustion at passage 7 under our culturing conditions. More than 80% of MEFs stained positive for SA-βgal activity when cultured for a
minimum of 10 days following either mode of senescence induction. Images were taken at 100X magniﬁcation. (B) Induction of senescence in MEFs caused intracellular copper
accumulation. ICP-MS analyses demonstrated that senescent MEFs (MEF IR) accumulated intracellular copper (~ 3-fold) at 21 days post-irradiation. Similarly, replicative senescent MEFs
(MEF REP) when cultured for 21 days at passage 7 also accumulated intracellular copper (~ 4-fold). (C) Changes in cell mass and volume of senescent cells did not account for copper
accumulation. Diameters of senescent cells in suspension (post-trypsinization) were found to be comparable to that of their primary precursor cells in suspension. Suspended cell diameter
was determined by Beckman Coulter Z Series Cell Count and Size Analyser (n=3) for all cell types being studied. Cellular protein content as a marker for overall cell mass and volume
was determined for all cell types under study. Senescent irradiated (MEF IR) and senescent replicative MEFs (MEF REP) contained ~ 1.3-fold and ~ 1.1-fold more protein when compared
to primary MEFs (MEF PRI), respectively. Oncogene induced senescent MEFs (MEF OIS) contained ~ 2.3-fold more protein than primary MEFs treated with control viral particles (MEF
VC). Senescent human prostate epithelial cells (PrEC IR) and senescent human diploid ﬁbroblasts (HDF IR) contained ~ 1.5-fold more protein than primary PrECs (PrEC PRI) and HDFs
(HDF PRI), respectively. Note that in each case the senescence associated fold change in copper content was higher than the fold change in total cellular protein content. Cellular protein
concentrations were determined using the BCA protein assay kit (Thermo Scientiﬁc) as per manufacturer's instructions. Total protein was determined as mg per 106 cells and represented
as mean± SD (n=3). (D) Copper accumulation in irradiated MEFs was concomitant with senescence, was p53-driven and was not indirectly caused by irradiation. Primary MEFs
isolated from mice harbouring mutant p53 (G515A nucleotide mutation), which impairs senescence induction by irradiation, displayed no signiﬁcant increase in intracellular copper post-
irradiation (10 Gy). Note that less than 20% of irradiated MEFs harbouring mutant p53 (IR p53mut) stained positive for SA-βgal activity when cultured for a minimum of 10 days following
irradiation. (E) Senescence bypass in MEFs by 3T3 subculture caused a limited increase in intracellular copper accumulation within the normal range of intracellular Cu in MEFs (see
Fig. 1F). ICP-MS analyses demonstrated that isogenic MEFs, which spontaneously bypassed senescence [ISO (3T3)], had intracellular copper levels comparable to that of primary MEFs
(MEF PRI). (F) Natural variance in intracellular copper in primary MEFs between diﬀerent embryonic linages. ICP-MS analyses of isogeneic C57BL/6 MEF lines (n=10) showed a range
of intracellular Cu (5.9–9.0 ng/106 cells) concentrations. Data represented as mean± range (n=10). (G) Senescence bypass in MEFs by immortalization caused no increase in in-
tracellular copper. (i) Primary MEFs were immortalized by transduction with retrovirus containing the SV40 large T antigen (LT) conﬁrmed through western blot analyses. (ii) ICP-MS
analyses demonstrated that immortalized MEFs (MEF LT) at passage 7 had intracellular copper levels comparable to that of primary MEFs (MEF PRI). (H) Induction of senescence in MEFs
with virus containing the oncogene H-RasV12 caused intracellular copper accumulation. (i) Primary MEFs transduced with virus containing H-RasV12 (OIS) were enriched for SA-βgal
positive cells (~ 50% at 8 days post-transduction) in comparison to primary MEFs transduced with control virus (VC) (~ 5%, not shown). (ii) ICP-MS analyses demonstrated that
oncogene-induced senescent MEFs (OIS) accumulated intracellular Cu (~ 3.5-fold) at 8 days post-transduction with virus containing H-RasV12. Immortalized MEFs transduced with virus
containing H-RasV12 (MEF LT Ras) had intracellular copper levels comparable to that of primary MEFs (PRI) and signiﬁcantly lower than MEF VC. (I) Induction of senescence by sub-lethal
gamma irradiation (10 Gy) caused intracellular copper accumulation in human diploid ﬁbroblast (HDFs) and human prostate epithelial cells (PrECs). (i) The majority (> 80%) of HDFs
and PrECs displayed positive SA-βgal activity 10 days post-irradiation. (ii) ICP-MS analyses demonstrated that senescent HDFs (HDF IR) and senescent PrECs (PrEC IR) accumulated 1.7-
fold and 2-fold more copper, respectively at 21 days post-irradiation compared to their respective non-irradiated primary cell. Statistical analysis was performed by student-t-test:
signiﬁcant (*p < 0.05, **p < 0.01, ***p < 0.001). Data represented as mean± SD (n=3) unless stated otherwise.
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(A)] MEFs were cultured for an additional 11 days to allow for a net
change in intracellular copper to occur (Fig. 3D(ii)). As expected, non-
irradiated primary Mobr MEFs (MEF-Mobr PRI) containing the wtAtp7a
mutation had markedly elevated levels of intracellular copper as a
baseline (Fig. 3D(ii)). When made senescent, these Mobr MEFs (MEF-
Mobr IR) further accumulated intracellular copper (~ 2-fold) (Fig. 3D
(ii)), surpassing levels previously observed in all other senescent cell
lines (Fig. 1).
Serially passaged primaryMobrMEFs displayed a remarkably similar
senescence induction proﬁle to wild-type MEFs (agouti or C57BL/6)
(Fig. 3E(i)). Additionally, copper accumulation in replicative senescent
Mobr MEFs (observed at passage 7) was comparable to that observed in
irradiated senescent Mobr MEFs (Fig. 3D, E(ii)). Therefore, it is unlikely
that elevated intracellular copper elicits more rapid induction or tran-
sition to cellular senescence. Previously, several groups demonstrated
premature senescence in human ﬁbroblasts induced through treatment
with high copper concentrations (250 and 500 μM CuSO4) [8,47,48].
Copper-induced cellular senescence was likely driven through ROS
generation [8], but did not occur in primary Mobr MEFs (passage 4)
despite these cells containing at least six-fold more intracellular copper
(Fig. 3D). This may be due to adaptation of the Mobr MEFs to manage
the gradual build-up of copper in these cells, in contrast to the acute
stress imposed by treatment with high levels of copper [8]. Taken to-
gether, these results suggest that enhanced copper levels do not ne-
cessarily drive senescence.
3.4. Senescence-associated copper accumulation is linked to impaired
autophagic-lysosomal function
We previously demonstrated that autophagic-lysosomal degradation
is impaired in senescent cells, contributing to iron dyshomeostasis
(impaired ferritinophagy) [44]. We therefore explored whether the
preservation of autophagic-lysosomal degradation in senescent cells
was suﬃcient to prevent copper accumulation. Rapamycin, an mTOR
inhibitor [35], activates autophagy and preserves lysosomal function in
senescent cells [68]. We treated primary MEFs with rapamycin
(100 nM) while they were irradiated (10 Gy) to undergo senescence and
sustained this treatment for 10 days. Cell culture medium was changed
twice over this time period and rapamycin treatment was maintained
with each medium change. Note that 10 days of culturing post-irra-
diation (10 Gy) is suﬃcient to achieve> 80% senescence in MEF cul-
tures (Fig. 1A). The LC3 protein in its lipidated form (LC3-II) normally
builds up in autophagosomes of cells and is degraded by lysosomal
proteases following autophagosome-lysosome fusion [51,70]. Thus, the
persistent accumulation of LC3-II in senescent cells indicates impair-
ment in lysosomal degradation and the resultant accumulation of au-
tophagosomes [44,70]. We therefore assessed LC3-II levels in rapa-
mycin treated irradiated MEFs 10 days post-irradiation and found that
levels of LC3-II were decreased, indicating that autophagic-lysosomal
degradation in rapamycin treated cells was preserved post-irradiation
(Fig. 4A). In addition to decreased LC3-II, the phosphorylated form of
Fig. 2. Senescent cells have altered copper homeostasis and en-
hanced antioxidant defence mechanisms. (A) Expression of key
copper homeostasis proteins was analysed in senescent MEFs
(MEF IR) at 21 days post-irradiation (IR, 10 Gy) by western blot
analyses and densitometry. Expression levels of Ctr1 (major
copper import protein) and Atp7a (main copper export protein)
were measured in comparison to primary (PRI) MEFs. β-actin was
detected as a loading control. (B) Expression of key copper de-
pendent proteins was analysed in senescent MEFs (MEF IR) at 21
days post-irradiation (IR, 10 Gy) by western blot analyses and
densitometry. Expression levels of superoxide dismutase 1 (SOD1)
(antioxidant cuproenzyme), CCS (copper chaperone for super-
oxide dismutase) and glutaredoxin 1 (Grx1) and were measured in
comparison to primary (PRI) MEFs. β-actin was detected as a
loading control. (C) Senescent MEFs (MEF IR) have elevated in-
tracellular glutathione. Reduced (GSH) and oxidized (GSSG)
glutathione were measured in primary (MEF PRI) and senescent
MEFs (MEF IR) at 21 days post-irradiation (10 Gy) by HPLC. The
GSH:GSSG ratio is also compared. Statistical analysis was per-
formed by student-t-test: signiﬁcant (*p < 0.05, ** p < 0.01,
***p < 0.001). Data represented as mean± SD (n=3).
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ribosomal protein S6 (pS6), a well-established marker of mTOR acti-
vation, also was diminished in rapamycin treated irradiated MEFs
(Fig. 4A). This observation was consistent with potentially enhanced
autophagy through the inhibition of mTOR [7]. These results suggest
that rapamycin treatment preserved the autophagic-lysosomal de-
gradation pathway in irradiated MEFs. Next, we assessed intracellular
copper levels in rapamycin treated irradiated MEFs and found a sig-
niﬁcant reduction in copper levels compared to untreated (basal) irra-
diated MEFs (Fig. 4B). In addition, once senescence was fully estab-
lished (10 days post-irradiation), subsequent rapamycin treatment
(100 nM for 4 days) mitigated intracellular copper accumulation
(Fig. 4C). However, when we assessed Atp7a levels in rapamycin
treated irradiated MEFs 10 days post-irradiation, we found that the
level of Atp7a was further diminished, possibly as a result of activated
autophagic-lysosomal degradation (Fig. 4D). Atp7a, analogous to the
related Atp7b, is likely to be degraded via the lysosomal and protea-
somal pathways [45]; however, senescent cells lack eﬃcient lysosomal
function [68]. Taken together these data suggest that copper accumu-
lation in senescent MEFs was linked to an impaired autophagic-lyso-
somal function and not a consequence of reduced Atp7a levels. One
possible mechanism to explain the copper accumulation is that copper
builds up in endocytic structures such as autophagosomes, multi-
vesicular bodies (MVB), or amphisomes. Autophagosomes can fuse with
MVBs and endosomes to generate amphisomes prior to fusion with
(caption on next page)
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lysosomes [26]. Autophagosomes, MVBs, or amphisomes may thus
serve as temporary sinks for elevated copper in non-senescent cells.
Subsequent export of copper then may occur through fusion of am-
phisomes/autophagosomes with the lysosome, followed by exocytic
fusion of the resultant auto-lysosome with the plasma membrane to
release the copper [14]. However, in senescent cells, due to lack of
lysosomal turnover of these structures, these accumulating autopha-
gosomes/ MVBs/amphisomes may continue to sequester copper, func-
tioning as a reservoir of copper. In support of this hypothesis, in-
tracellular multivesicular compartments have been observed to
accumulate in ATP7B-expressing CHO-K1 cells under conditions of
elevated copper [38]. ATP7B, a P1B-type transmembrane ATPase si-
milar to Atp7a but expressed highly in hepatocytes, is involved in
copper export and is localized to these compartments, suggesting that it
may traﬃc copper to these MVBs [57]. As we did not detect any ex-
pression of Atp7b transcript in primary or senescent MEFs (not shown)
it is possible that Atp7a follows a similar pathway in these cells. The
further copper accumulation seen in Atp7a deﬁcient Mobr MEFs com-
bined with that observed in autophagy-impaired senescent cells, sug-
gests that eﬃcient copper export requires both functional Atp7a and
autophagic-lysosomal function. This is supported by the cumulative
eﬀect on copper levels observed in senescent Mobr MEFs (Fig. 3D (ii)).
To test this hypothesis we treated primary MEFs with the lysosome
inhibitor baﬁlomycin A1 (Baf) with the aim of phenocopying, to a
limited extent, the eﬀects of perturbed autophagic-lysosomal degrada-
tion observed in senescent MEFs. Treating primary MEFs with Baf led to
a concomitant build-up of LC3-II levels (Fig. 4E), similar to our ob-
servations of lysosomal impairment in senescent MEFs (Fig. 4A). In-
terestingly, impairment of the autophagic-lysosomal degradation
pathway in primary MEFs treated for 16 h with 20 µM CuCl2 and Baf,
led to a signiﬁcant accumulation of copper, indicating the important
role of lysosomes in the export of copper from MEFs (Fig. 4F). Note that
Baf was previously shown to induce endosomal accumulation of Atp7a
as a consequence of perturbed endosomal recycling, which may also
contribute to the increased copper levels observed in primary cells
treated with Baf [56]. Thus, preservation and possible restoration of
autophagic-lysosomal function was suﬃcient to prevent (Fig. 4B) and
reverse (Fig. 4C), respectively, the copper accumulation phenotype in
senescent cells.
Fig. 3. Copper accumulation in senescent cells is saturable and limited by Atp7a. (A) Copper accumulation in irradiated (10 Gy) senescent MEFs (MEF IR) over prolonged culturing. ICP-
MS analyses demonstrated cumulative intracellular copper accumulation in irradiated (10 Gy) senescent MEFs (MEF IR) over the culturing time points indicated (day 1, 7, 14 and 21).
Note that copper accumulation plateaued after day 14. Baseline intracellular copper levels in primary MEFs (MEF PRI) are also shown. Percentage of senescent MEFs (MEF IR) over the
culturing time points indicated as SA-βgal positive activity. (B) Copper accumulation in MEFs undergoing replicative senescence (MEF REP). ICP-MS analyses demonstrated that copper
accumulated when replicative senescence commenced (< 10%) at passage 6 and was augmented with senescence enrichment (> 80%) at passage 7. Note copper accumulation plateaued
after culturing passage 7 senescent MEFs for 10 days (~ 5-fold) following which no further increase in copper was reported at day 21. Percentage of senescent MEFs in continually
passaged cultures (passages 4, 6 and 7) is indicated as percentage of cells with SA-βgal activity. (C) Capacity of senescent MEFs to accumulate copper is dependent on extracellular copper
concentration. Irradiated senescent MEFs (MEF IR, 14 days post irradiation) and replicative senescent MEFs (MEF REP P7, day 10), were cultured for 24 h in basal medium, or media
supplemented with 20 µM copper (as CuCl2). ICP-MS analyses revealed a greater increase in accumulated copper in IR senescent MEFs compared to replicative senescent MEFs following
copper treatment. The baseline and copper supplemented intracellular Cu level in primary (PRI) MEFs (P4) is also shown. (D) Senescent irradiated Mottled Brindled (Mobr) MEFs
accumulate substantial copper compared to senescent agouti MEFs. (i) Sub-lethal gamma irradiation (10 Gy) caused the majority (> 80%) of Mobr (MEF Mobr IR) and agouti MEFs[MEF
(A) IR] to display positive SA-βgal activity 10 days post-irradiation. Images were taken at 100X magniﬁcation. (ii) ICP-MS analyses demonstrated that senescentMobrMEFs (MEF Mobr IR)
accumulated intracellular copper (~ 2-fold) at 21 days post-irradiation compared to primary Mobr MEFs (MEF Mobr PRI). Intracellular copper levels of primary and irradiated senescent
agouti MEFs are shown for comparison. Note that intracellular copper in non-irradiated primaryMobr MEFs (MEF Mobr PRI) was highly elevated compared to wild type MEFs of C57BL/6
or agouti background. (E) Replicatively senescent Mottled Brindled (Mobr) MEFs accumulate substantial copper post senescence induction. (i) Primary (non-immortalized) Mobr and
agouti MEFs were induced to senescence by replicative exhaustion. Senescent cell population in culture was determined through staining for senescence-associated beta-galactosidase
(SA-βgal) activity (blue staining). Note that primary Mobr and agouti MEFs underwent replicative exhaustion at passage 7 under our culturing conditions. More than 80% of cells stained
positive for SA-βgal activity when cultured for a minimum of 10 days following senescence induction. Images were taken at 100×magniﬁcation. (ii) ICP-MS analyses demonstrated that
replicatively senescent Mobr MEFs (MEF Mobr P7) accumulated intracellular copper (~ 2-fold) at 21 days post senescence induction compared to primary Mobr MEFs (MEF Mobr PRI).
Statistical analysis was performed by student-t-test: signiﬁcant (*p < 0.05, **p < 0.01, ***p < 0.001). Data represented as mean± SD (n=3).
Fig. 4. Rapamycin treatment attenuates senescence-associated
copper accumulation. (A) Sustained rapamycin treatment pre-
serves autophagic-lysosomal function in irradiated MEFs. Western
blot analyses demonstrated that levels of LC3-II and phosphory-
lated ribosomal protein S6 (pS6) were signiﬁcantly reduced by
sustained treatment of irradiated MEFs for 10 days post-irradia-
tion (10 Gy) with rapamycin (100 nM). β-actin was detected as a
loading control. (B) Sustained rapamycin treatment limited in-
tracellular copper accumulation in irradiated MEFs. ICP-MS ana-
lyses demonstrated that irradiated MEFs subjected to sustained
treatment with rapamycin (100 nM) showed markedly reduced
copper accumulation at 10 days post-irradiation (10 Gy). (C)
Rapamycin treatment after senescence establishment reversed
intracellular copper accumulation in irradiated MEFs. ICP-MS
analyses demonstrated that senescent irradiated MEFs treated
with rapamycin (100 nM) for 4 days after senescence establish-
ment (10 days post-irradiation) reversed copper accumulation.
Statistical analysis was performed by student-t-test: signiﬁcant
(*p < 0.05, **p < 0.01, ***p < 0.001). Data represented as
mean± SD (n=3). (D) Sustained rapamycin treatment did not
enhance Atp7a levels. Western blot analyses and densitometry
demonstrated that levels of Atp7a did not increase by sustained
treatment of irradiated MEFs for 10 days post-irradiation (10 Gy)
with rapamycin (100 nM). β-actin was detected as a loading
control. (E) Baﬁlomycin A1 (Baf) treatment attenuates autop-
hagic-lysosomal function in primary MEFs. Western blot analyses
demonstrated that the level of LC3-II was signiﬁcantly elevated by treatment of primary MEFs with Baf (100 nM) for 16 h. β-actin was detected as a loading control. (F) Inhibition of
autophagic-lysosomal function enhanced intracellular copper accumulation in primary MEFs. Primary MEFs were cultured for 16 h in basal medium, or medium supplemented with
20 µM copper (as CuCl2), with or without Baf A1 (100 nM). ICP-MS analyses revealed a greater increase in accumulated copper in primary MEFs treated with Baf A1 compared to primary
MEFs without Baf A1 treatment following 16 h of Cu treatment. The baseline intracellular copper level in primary (PRI) MEFs (P4) is also shown.
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4. Conclusion
Our results demonstrate altered copper homeostasis is linked to
impaired autophagy in senescent cells. Signiﬁcantly, this study for the
ﬁrst time establishes a possible connection between Atp7a and the
autophagic-lysosomal pathway, indicating a requirement for both for
eﬃcient copper export. Our ﬁnding that the preservation and re-
activation of autophagic-lysosomal function by rapamycin in irradiated
MEFs resulted in a concomitant reduction in copper levels suggests a
possible and yet undeﬁned association between cellular autophagy,
Atp7a and copper export. A model to account for the observations in
this study is that lysosomal dysfunction in senescent cells leads to in-
creased Ctr1 and copper sequestration within accumulating autopha-
gosomes/MVBs/amphisomes via a functional Atp7a. This is in contrast
to Mobr MEFs, where autophagic-lysosomal function is intact but ab-
sence of a functional Atp7a leads to an accumulation of intracellular
copper (possibly non-compartmentalized). When both autophagic-ly-
sosomal function is impaired and Atp7a is absent in senescent Mobr
MEFs, copper accumulates even further. Hence, Atp7a likely functions
within the autophagic-lysosomal pathway and both are needed for ef-
ﬁcient copper export. Notably, in support of our model, Atp7a is known
to facilitate copper import in lysosome-related organelles such as mel-
anosomes [64] and phagosomes [75]. Further, the C-terminus of Atp7a
harbours a DKHSLL signature that conforms to the dileucine-based
motifs, DXXLL or [DE]XXXL[LI], that serve as lysosomal targeting sig-
nals [10,58]. While this suggests a speciﬁc and direct mode of transport
of Atp7a to the lysosomal membrane, the mode of delivery of copper to
the lysosome and the role of Atp7a still remains poorly deﬁned. The
observation that senescence induction leads to impaired autophagy
accompanied by altered copper homeostasis, suggests an important
interplay between lysosomal function and copper metabolism. We en-
visage that understanding this aspect of copper biology will have far
reaching consequences in the identiﬁcation of new molecular targets
and development of therapies to combat disorders linked to aberrations
in copper metabolism.
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